John Carstensen

7.4k total citations
162 papers, 5.5k citations indexed

About

John Carstensen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, John Carstensen has authored 162 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 42 papers in Cancer Research and 33 papers in Pathology and Forensic Medicine. Recurrent topics in John Carstensen's work include Cancer Genomics and Diagnostics (18 papers), Genetic factors in colorectal cancer (17 papers) and Breast Cancer Treatment Studies (13 papers). John Carstensen is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Genetic factors in colorectal cancer (17 papers) and Breast Cancer Treatment Studies (13 papers). John Carstensen collaborates with scholars based in Sweden, Norway and United States. John Carstensen's co-authors include Bo Nordenskjöld, Olle Stål, Sten Wingren, Thomas Hatschek, Gunnar Eklund, Göran Pershagen, Xiao‐Feng Sun, Kristina Alexanderson, Lars Erik Rutqvist and Lars‐Erik Holm and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

John Carstensen

159 papers receiving 5.3k citations

Peers

Countries citing papers authored by John Carstensen

Since Specialization

Citations

This map shows the geographic impact of John Carstensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Carstensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Carstensen more than expected).

Fields of papers citing papers by John Carstensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Carstensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Carstensen. The network helps show where John Carstensen may publish in the future.

Co-authorship network of co-authors of John Carstensen

This figure shows the co-authorship network connecting the top 25 collaborators of John Carstensen. A scholar is included among the top collaborators of John Carstensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Carstensen. John Carstensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of a chest drainage system on retained blood-associated complications after cardiac surgery 2025 ·European Journal of Cardio-Thoracic Surgery ·Jurij Matija Kališnik, (unknown), Janez Žibert, (unknown), (unknown), John Carstensen, (unknown), Theodor Fischlein	0
2	Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men 2014 ·British Journal of Dermatology ·Johan Lyth, Hanna Eriksson, Johan Hansson, Christian Ingvar, (unknown), Jan Lapins, Eva Månsson‐Brahme, Peter Naredi, Ulrika Stierner, Gustav Ullenhag, John Carstensen, C. Lindholm	30
3	NF-κB p65 phosphorylated at serine-536 is an independent prognostic factor in Swedish colorectal cancer patients 2011 ·International Journal of Colorectal Disease ·(unknown), (unknown), John Carstensen, Gunnar Arbman, Hong Zhang, Xiao‐Feng Sun	20
4	Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial 2011 ·Breast Cancer Research and Treatment ·Thomas Hatschek, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Linderholm, Birgitta Lindh, Niklas Loman, Martin Malmberg, S Rotstein, Martin Söderberg, M. Sundquist, Thomas Walz, Mats Hellström, Harry Svensson, Gunnar Åström, Yvonne Brandberg, John Carstensen, Mårten Fernö, Jonas Bergh	23
5	Migration and mortality trajectories: A study of individuals born in the rural community of Överkalix, Sweden 2011 ·Social Science & Medicine ·Petter Tinghög, John Carstensen, Gunnar Kaati, Sören Edvinsson, Michael Sjöstróm, Lars Olov Bygren	3
6	Co-morbidity and health care utilisation five years prior to diagnosis for depression. A register-based study in a Swedish population 2011 ·BMC Public Health ·David Andersson, Henrik Magnusson, John Carstensen, Lars Borgqúist	22
7	Plasma Levels of Matrix Metalloproteinase-9 are Independently Associated With Psychosocial Factors in a Middle-Aged Normal Population 2009 ·Psychosomatic Medicine ·Peter Garvin, (unknown), John Carstensen, Lena Jonasson, Margareta Kristenson	40
8	The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy 2009 ·Annals of Oncology ·(unknown), Jingfang Gao, Gunnar Adell, John Carstensen, Xiao‐Feng Sun	14
9	Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer 2008 ·Digestive and Liver Disease ·Jingfang Gao, (unknown), Gunnar Arbman, John Carstensen, B Frånlund, Xiao‐Feng Sun	48
10	Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma 1996 ·International Journal of Cancer ·Margareta Karlsson, Ulf Jungnelius, Steinar Aamdal, B Boeryd, John Carstensen, Bertil Kågedal, Ronny Westberg, Sten Wingren	32
11	Expression of c-erbB-2 and p53 in colorectal adenocarcinoma. 1995 ·PubMed ·(unknown), John Carstensen, Bo Nordenskjöld	8
12	P53 Expression and the Result of Adjuvant Therapy of Breast Cancer 1995 ·Acta Oncologica ·Olle Stål, Marie Stenmark Askmalm, Sten Wingren, Lars Erik Rutqvist, Lambert Skoog, (unknown), (unknown), John Carstensen, Bo Nordenskjöld	32
13	S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer 1994 ·British Journal of Cancer ·Olle Stål, Lambert Skoog, Lars Erik Rutqvist, John Carstensen, Sten Wingren, (unknown), Christin Andersson, Monika Dufmats, Bo Nordenskjöld	49
14	Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients 1993 ·European Journal of Cancer ·Sven Törnberg, John Carstensen	26
15	DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease 1993 ·British Journal of Cancer ·Margareta Karlsson, B Boeryd, John Carstensen, Bertil Kågedal, (unknown), Sten Wingren	11
16	Treatment Results and Prognostic Factors in a Population-Based Study of Epithelial Ovarian Cancer 1993 ·Gynecologic Oncology ·Thomas Högberg, John Carstensen, Ernst Simonsen	49
17	Deferred Treatment in Clinically Localised Prostatic Carcinoma 1992 ·British Journal of Urology ·Jan Adolfsson, John Carstensen, T Löwhagen	90
18	Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients 1992 ·British Journal of Cancer ·Olle Stål, John Carstensen, Thomas Hatschek, Bo Nordenskjöld	23
19	Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program 1989 ·Cancer ·Thomas Hatschek, G Fagerberg, Olle Stål, (unknown), John Carstensen, Otto Gröntoft, (unknown)	39
20	Persistance of intramuscular deposits of vitamin D3 in slaughter pigs. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·N. Bille, John Carstensen, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact